XML 49 R36.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Schedule of Warrants Activity

The following is a summary of the Company’s warrant activity:

 

    Warrants     Weighted
Average
Exercise Price
 
             
Outstanding – December 31, 2019     2,012,500     $ 0.43  
Exercisable – December 31, 2019     2,012,500     $ 0.43  
Granted     984,284     $ 0.48  
Exercised     -     $ -  
Forfeited/Cancelled     -     $ -  
Outstanding – December 31, 2019     6,849,635     $ 0.71  
Granted     3,116,230     $ 0.53  
Exercised     -     $ -  
Forfeited/Cancelled     (250,000 )   $ -  
Outstanding – December 31, 2020     9,715,865     $ 0.65  
Exercisable – December 31, 2020     9,715,865     $ 0.6  
Schedule of Warrants Outstanding and Exercisable
Warrants Outstanding     Warrants Exercisable  
Exercise Price    

Number

Outstanding

   

Weighted

Average

Remaining

Contractual

Life

(in years)

   

Weighted

Average

Exercise Price

   

Number

Exercisable

   

Weighted

Average

Exercise Price

 
                                 
$ 0.40 – 3.00       9,715,865       1.52 years     $ 0.65       9,715,865     $ 0. 65  
Schedule of Assumption Used Value of Options

For the year ended December 31, 2019, when computing fair value of share-based payments, the Company has considered the following variables:

 

   

December 31,

2019

 
Risk-free interest rate     2.50 %
Expected life of grants     3 years  
Expected volatility of underlying stock     168.71 %
Dividends     0 %